Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant [Phase 1]
A Phase 1 study evaluating tremelimumab with durvalumab, high-dose chemotherapy, and autologous stem cell transplant in multiple myeloma was…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma [Phase 1]
Phase 1 study of tabalumab (LY2127399) in Japanese patients with relapsed or refractory multiple myeloma has been completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L [Phase 2]
Phase 2 trial evaluating lenalidomide plus low-dose dexamethasone followed by stem cell collection and randomization to continued therapy or…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM [Phase 1, Phase 2]
A safety and dose-ranging study of samalizumab in relapsed or refractory CLL and multiple myeloma was terminated; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02 [Phase 2]
Phase 2 first-line treatment trial in multiple myeloma completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial update for ACVDL treatment in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating SRT501 alone or with bortezomib in multiple myeloma was terminated; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
The document reports a single-patient use of selinexor with dexamethasone for multiple myeloma in a clinical trial, noting that the study is…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial investigating selinexor (KPT-330) with liposomal doxorubicin for relapsed/refractory multiple myeloma has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated durvalumab in combination with lenalidomide with and without dexamethasone in adults with newly diagnos…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies [Phase 1, Phase 2]
This update reports phase 1/2 results for busulfan-fludarabine conditioning followed by T-cell depleted allogeneic stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain
This document notes the completion of a first-line treatment study for newly diagnosed transplant-ineligible multiple myeloma in Spain, spon…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated whether adding acupuncture to standard care reduces chemotherapy-induced peripheral neuropathy in patients with…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients [Phase 2]
A Phase 2 trial evaluating repeated dosing of a high-dose influenza vaccine in patients with gammopathy (including multiple myeloma and rela…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating inducible regulatory T cells (iTregs) in non-myeloablative sibling donor peripheral blood stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Treatment Optimization in Patients With Untreated Multiple Myeloma [Phase 2, Phase 3]
A Phase 2/3 clinical trial update on treatment optimization for untreated multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma [Phase 1]
Status update on a completed Phase 1 trial evaluating the combination of panobinostat and carfilzomib in patients with relapsed or refractor…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission [Phase 2]
Phase 2 trial evaluating an allogeneic GM-CSF vaccine with lenalidomide in myeloma patients near complete remission has completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation [Phase 2]
Phase 2 trial of Granix to disrupt the bone marrow microenvironment in patients with multiple myeloma undergoing autologous transplantation;…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation [Phase 3]
A Phase 3 clinical trial evaluating intensified daratumumab-based induction and consolidation in eligible newly diagnosed multiple myeloma p…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Redirected Auto T Cells for Advanced Myeloma [Phase 2]
Phase 2 clinical trial update for redirected autologous T cells in advanced multiple myeloma; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Pre-emptive Daratumumab Therapy of Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma [Phase 2]
Phase 2 trial evaluating pre-emptive daratumumab therapy for minimal residual disease reappearance or biochemical relapse in multiple myelom…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation with sirolimus and treated immune cells, for blood and lymph cancers, terminated wi…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States [Phase 2]
Phase 2 trial investigating reduced-intensity allogeneic peripheral blood stem cell transplantation for hematologic malignancies and hematop…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating masitinib in relapse or refractory multiple myeloma was terminated.